Researchers from Seoul National University have introduced a new type of biological containment system for genetically modified bacteria that irreversibly blocks their vital activity by editing DNA without cutting the double helix. This approach has the potential to change biosafety standards for industrial and therapeutic microorganisms.

Genetic "emergency kill switch" without DNA cleavage

In an article published in the journal "Nucleic Acids Research" in May 2026, the team describes the eEGM system – "editing-driven essential gene multiplex inactivation," a module for the multiplexed shutdown of essential genes via base editing.

The new platform uses a catalytically inactive version of CRISPR-Cas9, known as "dCas9," fused to the cytidine deaminase enzyme. Instead of creating double-strand breaks in the DNA – a process that can destabilize the genome and trigger unwanted mutations – the system performs precise changes to individual nucleotides in the start codons of key genes, thereby irreversibly stopping the synthesis of the corresponding proteins.

"This research offers a fundamentally new strategy for precise and irreversible control over the viability of microbial cells through base editing," emphasizes Professor Sang Woo Seo, the lead corresponding author of the publication. "We are convinced that this technology has strong potential as a next-generation biosafety platform."

The mechanism relies on "reprogramming" ATG start codons into non-functional alternatives. In this way, scientists figuratively "turn off the power buttons," without which bacteria cannot produce vital proteins. After a short induction signal, the resulting genetic changes are fixed and do not require the constant presence of the editing apparatus.

Multiplex targeting reduces the risk of "escaped" bacteria

One of the classic weaknesses of biocontrol systems is the appearance of so-called "escapers" – rare mutant cells that manage to avoid the killing mechanism and continue to multiply.

The Seoul team solves this problem by simultaneously targeting three different essential genes located in independent biological pathways: "holA," "ftsB," and "dfp." This multiplex design sharply reduces the probability of a cell "surviving" through a random mutation in all affected points.

The result is a bacterial escape frequency of 10⁻⁸ or lower within one hour after short-term induction – a value that meets the US National Institutes of Health criteria for reliable biocontainment systems (fewer than one "escaper" per 10⁸ cell units).

The eEGM system also demonstrates high portability: it was successfully tested on several different "E. coli" strains – the laboratory MG1655, the industrial W3110, and the probiotic Nissle 1917 – without disrupting the expression of the engineered genes that these bacteria were designed to carry.

Significance for industry and medicine

Classic CRISPR-Cas9-based "kill switch" systems kill cells by cutting DNA, but this mechanism often leads to off-target damage, activates repair mechanisms, and creates strong selective pressure. Over time, this can favor mutants that overcome the blockade and weaken the reliability of the biocontrol.

Alternative strategies based on CRISPRi use gene "silencing" without direct editing – this reduces toxicity but makes the effect reversible: upon the disappearance of the repressing signal, bacteria can restore normal growth.

The "eEGM" module occupies an intermediate position: it guarantees irreversibility comparable to systems that cut DNA, but with significantly lower basal toxicity, similar to CRISPRi approaches.

The authors see broad opportunities for application in the production of biofuels, biodegradable plastics, and other bioproducts, where genetically modified microorganisms operate in large bioreactors, as well as in the development of living biotherapeutic agents – for example, probiotic bacteria that deliver drugs or modulate the microbiome in the human body. In such cases, it is critically important to prevent uncontrolled multiplication or long-term colonization by the modified strains.

The researchers emphasize that before practical implementation, additional tests in complex ecological conditions are necessary to verify the stability and predictability of the system outside the laboratory. Nevertheless, "eEGM" already establishes base editing as a promising tool for the programmable and long-term biological containment of engineered microbes.